FLUDARABINE AND CYCLOPHOSPHAMIDE FOR THE TREATMENT OF PATIENTS WITH INDOLENT NON-FOLLICULAR (INFL) B-CELL NON-HODGKIN'S LYMPHOMAS. PRELIMINARY RESULTS OF A PHASE II TRIAL OF THE 'GRUPPO ITALIANO PER LO STUDIO DEI LINFOMI (GISL)